Challenges with Endoscopic Therapy for Barrett’s Esophagus

• Autores: Sachin Wani, Prateek Sharma
• Localización: Gastroenterology clinics of North America, ISSN 0889-8553, Vol. 44, Nº. 2, 2015 (Ejemplar dedicado a: Barrett’s Esophagus), págs. 355-372
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Barrett’s esophagus is the only identifiable premalignant condition for esophageal adenocarcinoma. Endoscopic eradication therapy (EET) has revolutionized the management of Barrett’s-related dysplasia and intramucosal cancer. The primary goal of EET is to prevent progression to invasive esophageal adenocarcinoma and ultimately improve survival rates. There are several challenges with EET that can be encountered before, during, or after the procedure that are important to understand to optimize the effectiveness and safety of EET and ultimately improve patient outcomes. This article focuses on the challenges with EET and discusses them under the categories of preprocedural, intraprocedural, and postprocedural challenges.